Table 5 Results obtained from the two methods
Adverse effect | Number of cases | |
|---|---|---|
IPRA | PAF | |
Decrease in vas deferens weight/adverse effect on testicular function | 4894 | -------- |
Increased T3 levels | 0 | 88,957–303,759 |
Early pubertal development | 0 | 281,923 |
Obesity | -------- | 7,199,228 |